Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze CE stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CE investment potential.

What is CE stock price today?

Get real-time CE stock price, historical data, and price charts on Financhill. Track CE performance with our advanced analysis tools.

Is CE a good investment?

Evaluate CE investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

To buy CE stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CE?

View detailed market capitalization data and company valuation metrics for CE on our comprehensive analysis page.

What is the P/E ratio of CE?

Use our fundamental analysis tools to view CE P/E ratio and compare valuation metrics with industry peers.

What are CE earnings?

View CE earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Celanese Corp. 10K Form

Buy

CE
Celanese Corp.

Last Price:

$64.11

Seasonality Move:

5.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-08	10Q	CE/Celanese Corp. Quarterly
2023-08-08	10Q	CE/Celanese Corp. Quarterly
2023-05-10	10Q	CE/Celanese Corp. Quarterly
2022-11-04	10Q	CE/Celanese Corp. Quarterly
2022-07-29	10Q	CE/Celanese Corp. Quarterly
2022-04-29	10Q	CE/Celanese Corp. Quarterly

Receive CE News And Ratings

See the #1 stock for the next 7 days that we like better than CE

CE Financial Statistics

Sales & Book Value

Annual Sales:	$9.5B
Cash Flow:	$168M
Price / Cash Flow:	8.82
Annual Sales:	$36.95
Price / Book:	1.79

Profitability

EPS (TTM):	-10.59060
Net Income (TTM):	$-1.1B
Gross Margin:	$1.8B
Return on Equity:	-21.86%
Return on Assets:	-4.95%

Celanese Corp. Earnings Forecast

Key Celanese Corp. Financial Ratios

The Gross Profit Margin over the past 25 years for CE is 18.82%.
The Selling, General & Administrative Expenses for CE have been equal to 9.42% of Gross Profit Margin.
The Research & Development expenses have been 1.31% of Revenue.
The Net Earning history of CE is -11.84% of Total Revenues.
Per Share Earnings over the last 25 years have been positive in 13 years.

Celanese Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Chemicals
Sector:	Materials
Current Symbol:	CE
CUSIP:	150870
Website:	celanese.com

Debt

Debt-to-Equity Ratio:	3.19
Current Ratio:	1.55
Quick Ratio:	0.6

Price-to-Earnings

Trailing P/E Ratio:	3.9
Forward P/E Ratio:	10.22

CE Technical Analysis vs Fundamental Analysis

Buy

Celanese Corp. (CE) is a Buy

Is Celanese Corp. a Buy or a Sell?

Celanese Corp. stock is rated a Buy

The current Celanese Corp. [CE] share price is $64.06. The Score for CE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.